Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4641059
Max Phase: Preclinical
Molecular Formula: C19H22ClN3O2S
Molecular Weight: 391.92
Molecule Type: Unknown
Associated Items:
ID: ALA4641059
Max Phase: Preclinical
Molecular Formula: C19H22ClN3O2S
Molecular Weight: 391.92
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c(C(=O)NN2C(=O)CSC23CCC(C)CC3)[nH]c2ccc(Cl)cc12
Standard InChI: InChI=1S/C19H22ClN3O2S/c1-11-5-7-19(8-6-11)23(16(24)10-26-19)22-18(25)17-12(2)14-9-13(20)3-4-15(14)21-17/h3-4,9,11,21H,5-8,10H2,1-2H3,(H,22,25)
Standard InChI Key: AXQNNCHBTSIHLK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 391.92 | Molecular Weight (Monoisotopic): 391.1121 | AlogP: 4.26 | #Rotatable Bonds: 2 |
Polar Surface Area: 65.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.39 | CX Basic pKa: | CX LogP: 3.85 | CX LogD: 3.85 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.80 | Np Likeness Score: -0.77 |
1. Cihan-Üstündağ G, Zopun M, Vanderlinden E, Ozkirimli E, Persoons L, Çapan G, Naesens L.. (2020) Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones., 28 (1): [PMID:31753804] [10.1016/j.bmc.2019.115130] |
Source(1):